Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 71INDUSTRY 14NIH 10NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Sarcoma 2

Conditions

Breast Neoplasms 10Lung Neoplasms 9Colorectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Rectal Neoplasms 7Adenocarcinoma of Lung 7Colonic Neoplasms 5Adenocarcinoma, Bronchiolo-Alveolar 4Glioblastoma 3Brain Neoplasms 3Ovarian Neoplasms 2Neoplasm Metastasis 2Inflammatory Breast Neoplasms 2Gliosarcoma 2Carcinoma 2Breast Neoplasms, Male 2Unspecified Adult Solid Tumor, Protocol Specific 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Oligodendroglioma 1Non Small Cell Lung Cancer Metastatic 1Meningioma 1Medulloblastoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Glioma 1Fallopian Tube Neoplasms 1Erythema Multiforme 1Ependymoma 1Cognition Disorders 1

Interventions

Radiotherapy 18Temozolomide 11Vincristine 10Filgrastim 9Etoposide 9Granulocyte Colony-Stimulating Factor 8Carboplatin 8Cyclophosphamide 7Radiotherapy, Intensity-Modulated 6Cisplatin 6Radiotherapy, Conformal 5Radiosurgery 5Peripheral Blood Stem Cell Transplantation 5Lomustine 5etoposide phosphate 4Thiotepa 3Immunohistochemistry 3Chemotherapy, Adjuvant 3Bevacizumab 3sargramostim 2Topotecan 2Psychiatric Rehabilitation 2Proton Therapy 2Procarbazine 2Microarray Analysis 2Mesna 2Mental Status and Dementia Tests 2Memantine 2In Situ Hybridization, Fluorescence 2Ifosfamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NETWORK × Brain Neoplasms × Bevacizumab × Clear all
NCT01730950 2022-12-29

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Radiation Therapy Oncology Group

Phase 2 Completed
182 enrolled 19 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT01290939 2021-02-15

Bevacizumab and Lomustine for Recurrent GBM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
592 enrolled
CNS

Brain Neoplasms, Cognition Disorders, Glioblastoma

NCT01164189 2019-02-28

TAVAREC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
155 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡